STOCKS TELEGRAPH

Tag: ZCMD stock

  • Zhongchao Inc. (ZCMD) Surges in Broader Chinese Low Float Rush

    Zhongchao Inc. (NASDAQ: ZCMD) experienced a remarkable surge in its stock price on Wednesday, initially rising by 22% during regular trading hours. However, the excitement didn’t stop there. In the after-hours session, the stock, driven by what appears to be a bullish frenzy, skyrocketed by an additional 30.5%, leaving investors buzzing with anticipation.

    Surge Amidst Uncertainty

    Zhongchao Inc., a prominent holding company, is known for its involvement in healthcare information, education, and training services. Its operations span across the Services and Drugs segments, offering a wide array of online and onsite healthcare services, education programs, and training products.

    Despite this surge, there seems to be a conspicuous absence of concrete news driving this rapid increase, leaving many investors wary of a potential profit-taking dip in the days to come. However, for now, bullish investors are content riding the wave of optimism.

    Market Dynamics and Concerns

    This surge coincides with a broader interest among traders, particularly in Chinese stocks, during the after-hours session. Stocks like ZCMD, characterized by their low float, become particularly susceptible to volatile price movements, making them enticing targets for short-term trading strategies.

    However, trading volume remains notably below average levels, prompting concerns among market observers. The opportunity, it seems, lies primarily within the extended hours trading window.

    Earlier Milestones

    Earlier last month, Zhongchao Inc. announced a significant milestone in its efforts to provide healthcare assistance to low-income patients suffering from Systemic Lupus Erythematosus (SLE). Through its subsidiary, Shanghai Zhongxin Medical Technology Co., Ltd., the company successfully provided medication assistance to over 7,000 SLE patients, alleviating their financial burdens associated with long-term treatment.

    This initiative points to Zhongchao’s commitment to leveraging its technical expertise to address critical healthcare needs. As investors navigate the volatile terrain of after-hours trading, the future trajectory of ZCMD remains uncertain, with market dynamics and underlying fundamentals shaping its course in the days ahead.

  • Zhongchao Inc. (ZCMD) stock Skyrockets Premarket After Plunging to New Low

    On March 14, Zhongchao Inc. (ZCMD) stock skyrocketed in the premarket to add an immense 60.00%. Thus, at the time of writing, the stock was trading at a price of $1.68 per share in the premarket. The volume of the shares exchanged was 754.2K at the time. There is no recent official announcement or SEC filing from the company.

    In the previous trading session on Friday, ZCMD fluctuated between $1.05 and $1.75 to report its new 52-week low of $1.05. The stock closed the session with a huge loss of 38.24% at a price of $1.05 per share.

    The healthcare information, education, and training services provider, Zhongchao Inc. is based in China.

    ZCMD’s Trend Reversal

    As the stock markets continued to suffer from the frenzy caused by the Russia-Ukraine conflict, ZCMD shared a similar fate. With healthcare stocks taking a harsh hit, ZCMD had also been going down since March 08. Continuing the downfall, the stock plunged to its new 52-week low of $1.05 on Friday. Consequently, the stock rebounded in the premarket session today. Since there is no recent news from the company, it seems the new low gave way to the recovery today. It is most likely that investors saw the new low price of the stock as a good opportunity to stock up. Hence, the stock rebounded and surged up in the premarket today due to external factors.

    It is unclear as to how long the current bullish momentum will continue as the market is highly volatile but for now, the stock is up for some good gains.

    Company News

    On October 29, the company announced updates regarding its self-developed patient management system. ZCMD’s patient management system improves the Duration of Therapy by 40.4% for patients with liver cancer. Therefore, contributing to maximum drugs efficiency, successful treatment, and extended patient survival terms.

    Source: HarmoniMD

    As per The Global Cancer Observatory, China had 400,000 new liver cancer cases in 2020. The main treatment of liver cancer currently includes surgical resection, interventional therapy, radiotherapy, and transplant. All these treatments have limitations specifically adverse reactions during the systemic therapies usually decrease life quality and negatively effects treatment. So, ZCMD closely monitors and deals with adverse reactions through its patient management system. Follow-up, psychological counseling, drugs usage reminder, and patient supervision all are done through the system.

    On September 17, the company announced the launch of its multidisciplinary treatment (MDT) clinical thinking training platform for hematology. This platform provides a channel for learning multidisciplinary thinking skills online. Hence, improving diagnosis and treatment along with efficiency.

  • 41 Stocks Taking Bigger Strides in Pre-Market Session

    41 Stocks Taking Bigger Strides in Pre-Market Session

    IMAC Holdings Inc. (IMAC) stock plunged -13.16% to $1.32 in the pre-market trading after the company reported third-quarter earnings. The most recent rating by Ascendiant Capital Markets, on April 15, 2020, is at a Buy.

    Allied Healthcare Products Inc. (NASDAQ: AHPI) shares are trading down -10.31% at $7.05 at the time of writing. The company’s 52-week range was noted as $0.92 to $45.00.

    EuroDry Ltd. (EDRY) tumbled over -16.9% at $5.9 in pre-market trading today following Company posted results for the nine-month period and quarter ending September 30, 2020.

    Pyxis Tankers Inc. (PXS), a Marine Shipping company, dropped about -11.86% at $1.04 in pre-market trading Friday as a result of publication stating announcement date of quarterly results and conferencing call.

    XPeng Inc. (XPEV) stock moved up 5.41 percent to $47.15 in the pre-market trading after the news that it has posted strong operating and financial results as a public company.

    Electra Meccanica Vehicles Corp. (SOLO) gained over 18.01% at $5.7 in pre-market trading Friday 13 November 2020 as the company posted robust 3rd quarter results.

    Li Auto Inc. (LI) is up more than 19.57% at $38.0 in pre-market hours Friday 13 November 2020 as the news appeared that the company has announced unaudited Q3 earnings. The stock had jumped over 27.27% to $31.78 in the last trading session.

    Before the trading started on 13 November 2020, Sino-Global Shipping America Ltd. (SINO) is down -7.02% to reach $2.25 following the company revealed earnings scores of fiscal 2020. It has been trading in a 52-week range of $1.37 to $4.89.

    Biocept Inc. (BIOC) stock plunged -15.42% to $5.21 in the pre-market trading as the firm posted third-quarter earnings. The most recent rating by Chardan Capital Markets, on November 14, 2017, is at a Buy.

    Fulgent Genetics Inc. (NASDAQ: FLGT) shares are trading up 6.63% at $41.0 at the time of writing after the news surfaced that company has reported record 3rd quarter earnings and raised its outlook for full-year 2020. The company’s 52-week range was noted as $6.70 to $52.47. Analysts have a consensus price target of $75.

    Zhongchao Inc. (ZCMD) tumbled over -10.7% at $1.92 in pre-market trading today after it was publicized that Zhongchao Inc. and Takeda pharmaceutical will expand the extent of collaboration in China.

    CBAK Energy Technology Inc. (CBAT), an Electrical Equipment & Parts company, rose about 28.46% at $5.1 in pre-market trading.

    Aeterna Zentaris Inc. (AEZS) lost over -11.11% at $0.32 in pre-market trading Friday 13 November 2020 as it was reported that the giant has announced its 3rd quarter earnings results as well provided business update.

    Northern Dynasty Minerals Ltd. (NAK) is down more than -4.5% at $0.885 in pre-market hours Friday 13 November 2020. The stock had jumped over 13.08% to $0.93 in the last trading session.

    Before the trading started on 13 November 2020, 9F Inc. (JFU) is down -9.68% to reach $1.12. It has been trading in a 52-week range of $0.72 to $11.41.

    Boxlight Corporation (BOXL) stock soared 4.97% to $1.69 in the pre-market trading after the news that the company is set to hold data for its Q3 earnings results and conference call. The most recent rating by National Securities, on May 19, 2020, is at a Buy.

    CureVac N.V. (NASDAQ: CVAC) shares are trading up 5.83% at $73.75 at the time of writing as cureVac’s COVID-19 vaccine candidate, CVnCoV, is suitable for standard fridge temperature Logistics. The company’s 52-week range was noted as $36.15 to $85.00.

    NIO Limited (NIO) grew over 5.57% at $50.99 in pre-market trading today as the news surfaced that the Chinese maker of electric vehicles, Nio Inc (NASDAQ: NIO), is facing intensified competition from Tesla Inc (NASDAQ: TSLA), which will only get more serious with the introduction of its China-made Model Y car.

    Revlon Inc. (REV), a Household & Personal Products company, dropped about -8.49% at $11.0 in pre-market trading Friday after the reports that company sales dropped during the third fiscal quarter.

    Kandi Technologies Group Inc. (KNDI) stock moved up 12.72 percent to $7.8 in the pre-market trading after it was revealed in the news that Kandi Technologies announced the closing of a registered direct placement of $60 million of common stock and warrants.

    Niu Technologies (NIU) gained over 4.49% at $33.29 in pre-market trading Friday 13 November 2020 as it was reported the company will announce its quarterly results on November 23, 2020.

    Onconova Therapeutics Inc. (ONTX) is down more than -10.86% at $0.2601 in pre-market hours Friday 13 November 2020 as news appeared that the company has issued a business update and reveled its quarterly earnings results. The stock had jumped over 7.99% to $0.29 in the last trading session.

    Before the trading started on 13 November 2020, Futu Holdings Limited (FUTU) is up 4.7% to reach $41.68 as it was publicized that the company’s stock will be added to the MSCI Hong Kong Small Cap Index. It has been trading in a 52-week range of $8.16 to $40.99.

    Fisker Inc. (FSR) stock soared 5.86% to $15.89 in pre-market trading. The most recent rating by Cowen, on November 09, 2020, is at an Outperform.

    Novavax Inc. (NASDAQ: NVAX) shares are trading up 5.43% at $95.8 at the time of writing. The company’s 52-week range was noted as $3.54 to $189.40 after the report that company loss widened in Q3 and revenues missed analysts’ estimates. Analysts have a consensus price target of $290.

    Kaixin Auto Holdings (KXIN) grew over 9.46% at $3.47 in pre-market trading today.

    Vipshop Holdings Limited (VIPS), an Internet Retail company, rose about 6.09% at $23.5 in pre-market trading Friday after the exciting news surfaced that the stock earnings beat analysts’ predictions.

    Inovio Pharmaceuticals Inc. (INO) stock moved up 4.75 percent to $11.9 in the pre-market trading after the company posted its third-quarter results.

    Fastly Inc. (FSLY) gained over 4.94% at $80.01 in pre-market trading Friday 13 November 2020.

    Verastem Inc. (VSTM) is up more than 4.64% at $1.58 in pre-market hours Friday 13 November 2020 after the company highlighted its recent progress along with its quarterly results. The stock had jumped over 5.59% to $1.51 in the last trading session.

    Before the trading started on 13 November 2020, NovaBay Pharmaceuticals Inc. (NBY) is down -19.99% to reach $0.52 as the company posted Q3 earnings reports. It has been trading in a 52-week range of $0.24 to $1.94.

    Digital Ally Inc. (DGLY) stock plunged -7.51% to $2.34 in the pre-market trading after the publication of the company’s Q3 operating results. The most recent rating by Aegis Capital, on June 29, 2020, is at a Buy.

    Jumia Technologies AG (NYSE: JMIA) shares are trading up 5.01% at $14.25 at the time of writing after the company said that it has managed to cut down on losses after making a strategic shift due to covid-19. The company’s 52-week range was noted as $2.15 to $23.90. Analysts have a consensus price target of $4.50.

    JD.com Inc. (JD) grew over 4.83% at $90.55 in pre-market trading today after the company revealed the date of its earnings call.

    Creative Realities Inc. (CREX), a Software – Application company, dropped about -15.53% at $0.87 in pre-market trading Friday as the company reported its third-quarter 2020 results.

    Myovant Sciences Ltd. (MYOV) stock moved up 6.43 percent to $18.22 in the pre-market trading following Corporate Updates and Financial Results for the second-quarter fiscal year 2020.

    Cassava Sciences Inc. (SAVA) lost over -19.59% at $8.99 in pre-market trading Friday 13 November 2020 as Cassava Sciences announced a proposed public offering of common stock.

    Four Seasons Education (Cayman) Inc. (FEDU) is down more than -6.41% at $0.82 in pre-market hours Friday 13 November 2020. The stock had jumped over 2.82% to $0.88 in the last trading session.

    Before the trading started on 13 November 2020, Bionano Genomics Inc. (BNGO) is down -6.65% to reach $0.535 as the company revealed its latest business update along with quarterly earnings results. It has been trading in a 52-week range of $0.25 to $1.39.

    Blink Charging Co. (BLNK) stock plunged -5.94% to $9.82 in the pre-market trading as the company revealed both quarterly and nine-month 2020 results. The most recent rating by H.C. Wainwright, on August 14, 2020, is at a Neutral.

    Farfetch Limited (NYSE: FTCH) shares are trading up 15.71% at $50.0 at the time of writing as the company posted Q3 earnings results. The company’s 52-week range was noted as $5.99 to $44.73. Analysts have a consensus price target of $42.

    Kensington Capital Acquisition Corp. (KCAC) grew over 11.19% at $15.9 in pre-market trading today after the company announced on November 25, 2020, a special meeting will be held to approve the business combination.

    Aytu BioScience Inc. (AYTU), a Biotechnology company, dropped about -2.93% at $0.9998 in pre-market trading Friday following Aytu BioScience announced fiscal Q1 2021 net revenue of $13.5 Million, an increase of 839% year-over-year.

    Palatin Technologies Inc. (PTN) stock moved up 4.22 percent to $0.4151 in the pre-market trading after it reports 1st quarter and fiscal year 2021 results; Teleconference and Webcast to be held on November 17, 2020.

    SPI Energy Co. Ltd. (SPI) gained over 5.43% at $8.15 in pre-market trading Friday 13 November 2020.

    Nabriva Therapeutics plc (NBRV) stock soared 6.41% to $0.45 in the pre-market trading. The most recent rating by Wedbush, on March 19, 2020, is at a Neutral. Nabriva Therapeutics to Participate in Upcoming Virtual Investor Conferences.

    Timber Pharmaceuticals Inc. (AMEX: TMBR) shares are trading up 5.32% at $0.99 at the time of writing after the announcement of the business update and 3rd quarter results. The company’s 52-week range was noted as $0.87 to $12.60.